Argus
•
Jan 15, 2025
IRWD: Lowering target price to $3.00
Summary
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operat
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Pfizer Inc.
May 05, 2026
•
PFE
Analyst Report: Alnylam Pharmaceuticals, Inc.
May 01, 2026
•
ALNY
Analyst Report: Amgen Inc.
May 01, 2026
•
AMGN
Analyst Report: Incyte Corp
Apr 30, 2026
•
INCY
Market Update: NDAQ, HON, IEX, INCY, OMC, TMUS, TMO, BKR
Apr 30, 2026
•
TMUS, NDAQ, OMC, HON, TMO, BKR, INCY, IEX
